Roivant Sciences (ROIV) Total Non-Current Liabilities (2021 - 2026)

Roivant Sciences has reported Total Non-Current Liabilities for 6 years, with the latest figure at $11.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 35.5% year-over-year to $11.9 million; the trailing twelve-month figure through Mar 2026 stood at $11.9 million (down 35.5% YoY), and the FY2026 full-year result was $11.9 million, down 35.5% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $11.9 million, down from $4.0 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $4.0 billion in Q4 2025, with the low at $11.9 million in Q1 2026.
• Historically, Total Non-Current Liabilities has averaged $748.9 million across 5 years, with a median of $668.6 million in 2023.
• Annual changes were most pronounced in 2024 — Total Non-Current Liabilities plunged 97.99% — and 2025, when it jumped 225.93%.
• Roivant Sciences' Total Non-Current Liabilities stood at $754.3 million in 2022, then fell by 11.36% to $668.6 million in 2023, then jumped by 85.04% to $1.2 billion in 2024, then jumped by 225.93% to $4.0 billion in 2025, then plunged by 99.71% to $11.9 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $11.9 million (Q1 2026), $4.0 billion (Q4 2025), and $257.0 million (Q3 2025), per Business Quant data.